Så er den gal igen. Novo Nordisks aktiekurs styrtdykker med omkring 14 procent mandag. Det hele begyndte en sensommerdag i 2022.

Novo Nordisk's stock dropped significantly after new data showed its experimental weight-loss drug Cagrisema was less effective than Eli Lilly's tirzepatide.

Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.

Eli Lilly has unveiled long-term data regarding its drug Omvoh, specifically for the treatment of Crohn's disease.

Lilly announced that a regimen including its drug Zepbound demonstrated success in a clinical trial for treating psoriasis.

CSL has entered into a licensing agreement with Eli Lilly for clazakizumab, a treatment for kidney disease.

Eli Lilly has delivered positive news for investors, with implications that reach beyond its well-known weight-loss drug portfolio.

Eli Lilly (LLY) is reportedly expanding its pharmaceutical pipeline through a new agreement involving Clazakizumab, as reported by Reuters.

Eli Lilly's experimental cancer drug has shown promise in reducing the risk of recurrence in patients with early-stage lung cancer.

An analyst suggests Eli Lilly stock is a strong buy-and-hold investment, citing reasons to never sell.

Eli Lilly is making a significant $1 billion investment in artificial intelligence, aiming to revolutionize drug discovery and development.

The initial excitement surrounding GLP-1 weight loss drugs provides insights into current market dynamics, with connections drawn to jet fuel and software sell-offs.

France24 offers a cultural tour of Paris, featuring actor and comedian Michel Boujenah alongside the musical group Lilly Wood & the Prick.

President Trump is raising his threatened global tariff to 15%, and Eli Lilly triumphs over obesity rival Novo Nordisk once again.

Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as much weight as an Eli Lilly product.

Lilly Larson drives six hours a week to train for gymnastics, demonstrating her dedication despite living an hour away from the nearest gym.

Jim Cramer shares his insights on Eli Lilly (LLY) and the growing market for weight loss drugs.

Eli Lilly and Company (LLY) stock has risen due to the expansion of Medicare coverage for GLP-1 weight loss drugs, which has alleviated pricing concerns.

Eli Lilly is eyeing India as a global export hub for its Mounjaro drug, driven by surging sales.

Investors are advised to keep an eye on Shopify, Eli Lilly, General Mills, and Norwegian Cruise Line Holdings as key stocks to watch on Tuesday.

The weight-loss drug market is rapidly expanding globally, with a shift from injections to pills and intense competition between pharmaceutical giants like Novo Nordisk and Eli Lilly. Regulatory scrutiny is also impacting new product offerings in this lucrative sector.